Mark Evans, the group’s CEO, explained that the purchase reflects the company’s desire to integrate a high-potential range into its portfolio; indeed, the Australian-built Cure catamarans have, in a remarkably short time, established an enviable reputation in the high-performance multihull segment. Production will now be distributed across McConaghy’s international facilities, thanks to its close connection with the Sydney headquarters and its ongoing collaboration with Cure’s original design team.
McConaghy has already begun development of the Cure 48GT and Cure 55GT models, updated evolutions of the 48 and 55.